Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 31 AL 45

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

de la Monte SM.

Curr Alzheimer Res. 2012 Jan;9(1):35-66. doi: 10.2174/156720512799015037.

Ethnobotanical treatment strategies against Alzheimer's disease

Howes MJ, Houghton PJ.

Curr Alzheimer Res. 2012 Jan;9(1):67-85. doi: 10.2174/156720512799015046.

Therapeutic targeting of the endoplasmic reticulum in Alzheimer's disease

Chadwick W, Mitchell N, Martin B, Maudsley S.

Curr Alzheimer Res. 2012 Jan;9(1):110-9. doi: 10.2174/156720512799015055.

Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease

Dubois B, Zaim M, Touchon J, Vellas B, Robert P, Murphy MF, Pujadas-Navinés F, Rainer M, Soininen H, Riordan HJ, Kanony-Truc C.

J Alzheimers Dis. 2012;29(3):527-35. doi: 10.3233/JAD-2012-111370.

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease

Jaturapatporn D, Isaac MG, McCleery J, Tabet N.

Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD006378. doi: 10.1002/14651858.CD006378.pub2.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170.

A grand plan for Alzheimer's disease and related dementias

Lancet Neurol. 2012 Mar;11(3):201. doi: 10.1016/S1474-4422(12)70026-1.

In vitro and in vivo comparisons of the effects of the fruiting body and mycelium of Antrodia camphorata against amyloid β-protein-induced neurotoxicity and memory impairment

Wang LC, Wang SE, Wang JJ, Tsai TY, Lin CH, Pan TM, Lee CL.

Appl Microbiol Biotechnol. 2012 Jun;94(6):1505-19. doi: 10.1007/s00253-012-3941-3. Epub 2012 Feb 21.

Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design

Speck-Planche A, Luan F, Cordeiro MN.

Curr Med Chem. 2012;19(11):1635-45. doi: 10.2174/092986712799945058.

Could antivirals be used to treat Alzheimer's disease?

Itzhaki RF, Wozniak MA.

Future Microbiol. 2012 Mar;7(3):307-9. doi: 10.2217/fmb.12.10.

Donepezil and memantine for moderate-to-severe Alzheimer's disease

Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P.

N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668.

Discontinuing donepezil or starting memantine for Alzheimer's disease

Schneider LS.

N Engl J Med. 2012 Mar 8;366(10):957-9. doi: 10.1056/NEJMe1200429.

Drugs for Alzheimer's disease

Ritter JM.

Br J Clin Pharmacol. 2012 Apr;73(4):501-3. doi: 10.1111/j.1365-2125.2012.04217.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias